The First Biologic Approved to Treat PMR: A Clinical Deep Dive
ASCVD Risk Reduction in Patients With T2D
Joshua Stolker, MD
PeerFrom Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Digital Mental Health Treatments, Part 1: The Role of Neurobehavioral Therapies in MDD
Digital Mental Health Treatments, Part 2: Utilizing Neuroplasticity in Digital Therapies
Patient Simulations in PAH: Understanding Objective Risk Assessment & Exploring Treatment Escalation in PAH Care
Bindu Akkanti, MD
PeerComparing Targeted Therapies for Wild-Type RAS Metastatic Colorectal Cancer
Combatting the Surge of Chlamydia & Gonorrhea with Universal Screening
When Treating IBS-D, It’s Important to Consider the Whole Picture
Darren Brenner, MD
PeerThe Role of Dysbiosis in the Pathophysiology of IBS-D
Christopher Chang, MD, PhD
PeerIBS-D Management Strategies: A Panel’s Perspective
Investigating an IBS-D Therapy: Key Findings From Clinical Trial & Practice Settings
The ASCVD Journey With Lp(a): An ApoB-Family Lipoprotein
Understanding Lp(a): Clinical Implications of an Underrecognized Genetic Dyslipidemia
Santica Marcovina, PhD, ScD
PeerLetters From the Heart: People Should Know About Lp(a)